Twinbeech Capital LP Acquires New Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Twinbeech Capital LP bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 187,486 shares of the real estate investment trust's stock, valued at approximately $3,800,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Two Sigma Advisers LP acquired a new position in shares of Healthpeak Properties in the 4th quarter valued at $5,691,000. State of Wyoming increased its holdings in shares of Healthpeak Properties by 113.6% in the fourth quarter. State of Wyoming now owns 9,153 shares of the real estate investment trust's stock worth $186,000 after acquiring an additional 4,867 shares in the last quarter. Toronto Dominion Bank raised its position in shares of Healthpeak Properties by 32.3% during the fourth quarter. Toronto Dominion Bank now owns 463,115 shares of the real estate investment trust's stock worth $9,387,000 after purchasing an additional 113,182 shares during the period. Systematic Financial Management LP lifted its holdings in shares of Healthpeak Properties by 3.7% during the 4th quarter. Systematic Financial Management LP now owns 1,472,448 shares of the real estate investment trust's stock valued at $29,847,000 after purchasing an additional 52,061 shares in the last quarter. Finally, Royal Bank of Canada grew its position in shares of Healthpeak Properties by 52.5% in the 4th quarter. Royal Bank of Canada now owns 1,080,999 shares of the real estate investment trust's stock valued at $21,913,000 after purchasing an additional 372,324 shares during the period. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

Shares of DOC stock traded up $0.04 on Monday, hitting $16.86. 5,878,293 shares of the company's stock were exchanged, compared to its average volume of 5,080,581. The company has a 50 day moving average of $18.46 and a 200 day moving average of $19.86. The stock has a market cap of $11.71 billion, a P/E ratio of 48.17, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same period in the prior year, the company earned $0.45 EPS. The firm's quarterly revenue was up 15.9% compared to the same quarter last year. On average, equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which will be paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's payout ratio is presently 305.00%.

Analyst Ratings Changes

DOC has been the topic of several analyst reports. Argus reaffirmed a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Scotiabank dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a report on Monday, May 12th. Robert W. Baird reduced their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Finally, Evercore ISI decreased their target price on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $23.45.

Insider Buying and Selling at Healthpeak Properties

In other news, Director Tommy G. Thompson acquired 5,700 shares of the firm's stock in a transaction dated Friday, May 9th. The stock was bought at an average cost of $17.36 per share, for a total transaction of $98,952.00. Following the completion of the transaction, the director now directly owns 138,513 shares in the company, valued at $2,404,585.68. This represents a 4.29% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Scott M. Brinker bought 2,750 shares of the stock in a transaction on Friday, May 9th. The stock was acquired at an average price of $17.39 per share, with a total value of $47,822.50. Following the completion of the acquisition, the chief executive officer now owns 204,613 shares of the company's stock, valued at $3,558,220.07. This represents a 1.36% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 23,987 shares of company stock worth $422,141. Insiders own 0.23% of the company's stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.